SEARCH

SEARCH BY CITATION

References

  • 1
    Lee WM. Hepatitis B virus infections. N Engl J Med 1997; 337: 1733.
  • 2
    Chiaramonte M, Pupo A, Menegon T, et al. HBV and HCV infection among non-European Union immigrants in North-East Italy. Epidemiol Infect 1998; 121: 17983.
  • 3
    Hemminki K, Mousavi SM, Brandt A, Ji J, Sundquist J. Liver and gallbladder cancer in immigrants to Sweden. Eur J Cancer 2010; 46: 92631.
  • 4
    Chiaramonte M, Pupo A, Menegon T, et al. HBV and HCV infection among non-European Union immigrants in North-East Italy. Epidemiol Infect 1998; 121: 17983.
  • 5
    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
  • 6
    Khalfa S, Ardjoun H. Epidemiology of viral hepatitis in Algeria (French). Med Trop (Mars) 1984; 44: 24752.
  • 7
    Ayed Z, Houinato D, Hocine M, Ranger-Rogez S, Denis F. Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria (French). Bull Soc Pathol Exot 1995; 88: 2258.
  • 8
    Khelifa F, Thibault V. Characteristics of hepatitis B viral strains in chronic carrier patients from North-East Algeria (French). Pathol Biol (Paris) 2009; 57: 10713.
  • 9
    Elzouki AN. Hepatitis B, C and HIV infection in Libya. Libyan J Infect Dis 2007; 1: 1323.
  • 10
    Khmmaj A, Habas E, Azabi M, Rayani A. Frequency of hepatitis B, C, and HIV viruses among blood donors in Libya. Libyan J Med 2010; 5: 5333.
  • 11
    Elzouki AN. Hepatitis B infection in Libya: The magnitude of the problem. Libyan J Infect Dis 2008; 2: 205.
  • 12
    El-Magrahe H, Furarah AR, El-Figih K, El-Urshfany S, Ghenghesh KS. Maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Tripoli, Libya. J Infect Dev Ctries 2010; 4: 16870.
  • 13
    ELahmer O, Zorgani A, Abudher A, Ziglam H. Prevalence of human immunodeciency virus, hepatitis B virus, hepatitis C virus among prison inmates, western Libya. The 22nd Annual European Congress of Clinical Microbiology and Infectious Diseases 2012, (Abstract).
  • 14
    Ezzikouri S, Chemin I, Chafik A, et al. Genotype determination in Moroccan hepatitis B chronic carriers. Infect Genet Evol 2008; 8: 30612.
  • 15
    Djeriri K, Laurichesse H, Merle JL, et al. Hepatitis B in Moroccan health care workers. Occup Med (Lond) 2008; 58: 41924.
  • 16
    Sbai A, Baha W, Ougabrai H, et al. Hepatitis B prevalence and risk factors in Morocco. Pathol Biol(Paris) 2012; 60: e659.
  • 17
    Zohoun A, Hadef R, Zahid H, Benkirane M. Seroprevalence of HBV and HCV in blood donors at the Blood Transfusion Center of Mohammed V Military Teaching Hospital in Rabat Morocco (French). Med Trop (Mars) 2011; 71: 5134.
  • 18
    Heikel J, Sekkat S, Bouqdir F, et al. The prevalence of sexually transmitted pathogens in patients presenting to a Casablanca STD clinic. Eur J Epidemiol 1999; 15: 7115.
  • 19
    Benjelloun S, Bennani A, Sekkat S, Benslimane A. Les hépatites virales au Maroc. Aspects épidémiologique et moléculaire. Journées scientifiques de medecine 2002; 604 (Abstract).
  • 20
    Belbacha I, Cherkaoui I, Akrim M, Dooley KE, El Aouad R. Seroprevalence of hepatitis B and C among barbers and their clients in the Rabat region of Morocco. East Mediterr Health J 2011; 17: 9119.
  • 21
    Aqodad N, Lahbabi M, Elyousfi M, et al. Prevalence of VHC-Ab and HBsAg among blood donors in Guelmim in the south of Morocco. Hep Intl 2011; 5/11936-0533.
  • 22
    Sekkat M. Prévalene de l'Ag HBs chez les femmes enceintes résulats préliminaires d'une étude prospective menée au CHU Hassan II fès Maroc a propos de 156 cas fès: Sidi Mohammed Ben Abdellah, 2010, (Thesis).
  • 23
    Rouibaa F, Acharki M, Amrani L, et al. Prevalence of Hepatitis B and C markers in high risk hospitalized patients in Morocco. Arab J Gastroenterol 2008; 9: 704.
  • 24
    Boulaajaj K, Elomari Y, Elmaliki B, et al. Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca (French). Nephrol Ther 2005; 1: 27484.
  • 25
    Lo BB, Meymouna M, Boulahi MA, et al. Prevalence of serum markers of hepatitis B and C virus in blood donors of Nouakchott, Mauritania (French). Bull Soc Pathol Exot 1999; 92: 834.
  • 26
    Lepers JP, Billon C, Pesce JL, Rollin PE, De Saint-Martin J. Sero-epidemiological study in Mauritania (1985–1986): incidence of treponematosis, hepatitis B virus, HIV virus and viral hemorrhagic fevers (French). Bull Soc Pathol Exot Filiales 1988; 81: 2431.
  • 27
    Mansour W, Malick FZ, Sidiya A, et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J Med Virol 2012; 84: 118698.
  • 28
    Rui WZ, Lo Baidy B, N'Diaye M. Hepatitis B virus infection in the school milieu of Kiffa and Selibaby, Mauritania (French). Bull Soc Pathol Exot 1998; 91: 2478.
  • 29
    Mansour W, Aye M, Le Gal F, et al. Impact of Hepatitis B and Delta Viruses Coinfection on Liver Disease in Mauritania. EASL Monothematic Conference: Delta Hepatitis Turkey, Istanbul, 2010;. (Abstract).
  • 30
    Mansour W, Bollahi MA, Hamed CT, et al. Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott. Mauritania. J Clin Virol 2012; 55: 126.
  • 31
    Gorgi Y, Ayed K, Jenhani F, Pichoud C, Trepo C. Prevalence of viral hepatitis B markers in the region of Tataouine (southern Tunisia) (French). Arch Inst Pasteur Tunis 1989; 66: 25161.
  • 32
    Triki H, Ben Slimane S, Ben Mami N, et al. High circulation of hepatitis B virus (HBV) precore mutants in Tunisia, North Africa. Epidemiol Infect 2000; 125: 16974.
  • 33
    Triki H, Said N, Ben Salah A, et al. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 1997; 91: 114.
  • 34
    Jemni L, Chatti N. Epidemiology of hepatitis B virus infection. Tunisie Maghreb Medical 1994; 278: 1518.
  • 35
    Hannachi N, Bahri O, Mhalla S, et al. Hepatitis B virus infection in Tunisian pregnant women: risk factors and viral DNA levels in HBe antigen negative women (French). Pathol Biol (Paris) 2009; 57: e437.
  • 36
    Ben-Alaya-Bouafif N, Bahri O, Chlif S, et al. Heterogeneity of hepatitis B transmission in Tunisia: risk factors for infection and chronic carriage before the introduction of a universal vaccine program. Vaccine 2010; 28: 33017.
  • 37
    Hannachi N, Boughammoura L, Marzouk M, et al. Viral infection risk in polytransfused adults: seroprevalence of seven viruses in central Tunisia (French). Bull Soc Pathol Exot 2011; 104: 2205.
  • 38
    Langar H, Triki H, Gouider E, et al. Blood-transmitted viral infections among haemophiliacs in Tunisia (French). Transfus Clin Biol 2005; 12: 3015.
  • 39
    Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 1995; 38: 2434.
  • 40
    Kitab B, El Feydi AE, Afifi R, et al. Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. J Infect 2011; 63: 6675.
  • 41
    Borchani-Chabchoub I, Gargouri A, Mokdad-Gargouri R. Genotyping of Tunisian hepatitis B virus isolates based on the sequencing of preS2 and S regions. Microbes Infect 2000; 2: 60712.
  • 42
    Malkin JE, Druilhe P, Courouce AM, Monjour L, Gentilini M. Geographical and ethnical distribution of HBs antigen subtypes in Mauritania. Rev Fr Transfus Immunohematol 1983; 26: 5917.
  • 43
    Couroucé-Pauty A, Plançon A, Soulier JP. Distribution of HBsAg subtypes in the World. Vox Sang 1983; 44: 197211.
  • 44
    Okamoto H, Tsuda F, Sakugawa H, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988; 69: 257583.
  • 45
    Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994; 198: 489503.
  • 46
    Kramvis A, Arakawa K, Yu MC, et al. Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. J Med Virol 2008; 80: 2746.
  • 47
    Stuyver L, De Gendt S, Van Geyt C, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000; 81: 6774.
  • 48
    Olinger CM, Jutavijittum P, Hubschen JM, et al. Possible new hepatitis B virus genotype, Southeast Asia. Emerg Infect Dis 2008; 14: 177780.
  • 49
    Tran TT, Trinh TN, Abe K. New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 2008; 82: 565763.
  • 50
    Kurbanov F, Tanaka Y, Kramvis A, Simmonds P, Mizokami M. When should “I” consider a new hepatitis B virus genotype? J Virol 2008; 82: 82412.
  • 51
    Tatematsu K, Tanaka Y, Kurbanov F, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 2009; 83: 1053847.
  • 52
    Alnagih NM, Bashein AM, Rayes A. HBV genotype D is the most prevalent in Libyan patients. Infectious & Endemic Diseases Scientific Conference 2007; 3536 (Abstract).
  • 53
    Sbai A, Bennani A, Benjouad A, Hassar M. HBV genotypes in Morocco. J Clin Virol 2007; 38: 1845.
  • 54
    Baha W, Ennaji MM, Lazar F, et al. HBV genotypes prevalence, precore and basal core mutants in Morocco. Infect Genet Evol 2012; 12: 115762.
  • 55
    Bahri O, Cheikh I, Hajji N, et al. Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia. J Med Virol 2006; 78: 3537.
  • 56
    Ayed K, Gorgi Y, Ayed-Jendoubi S, et al. Hepatitis B virus genotypes and precore/core-promoter mutations in Tunisian patients with chronic hepatitis B virus infection. J Infect 2007; 54: 2917.
  • 57
    Hannachi N, Fredj NB, Bahri O, et al. Molecular analysis of HBV genotypes and subgenotypes in the Central-East region of Tunisia. Virol J 2010; 7: 302.
  • 58
    Meldal BH, Moula NM, Barnes IH, Boukef K, Allain JP. A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 2009; 90: 16228.
  • 59
    Laras A, Koskinas J, Hadziyannis SJ. In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoter. Virology 2002; 295: 8696.
  • 60
    Jammeh S, Tavner F, Watson R, Thomas HC, Karayiannis P. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol 2008; 89: 9019.
  • 61
    Du H, Li T, Zhang HY, et al. Correlation of hepatitis B virus (HBV) genotypes and mutations in basal core promoter/precore with clinical features of chronic HBV infection. Liver Int 2007; 27: 2406.
  • 62
    Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 2: 58891.
  • 63
    Elzouki AN, Belkhair S, Tumi A, Abdulmoti S, Arabi M. Comparison between HBe antigen-negative patients and HBe antigen-positive patients with chronic hepatitis B infection in Benghazi, Libya. Libyan J Infect Dis 2007; 1: 2631.
  • 64
    Benjelloun S, Tong S, Li J, et al. Pre-core mutation associated with lack of hepatitis B e antigenaemia in Moroccan asymptomatic carriers of the virus. Res Virol 1993; 144: 15967.
  • 65
    Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia. J Gastroenterol Hepatol 2008; 23: 47481.
  • 66
    Li MS, Lau TC, Chan SK, et al. The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity. PLoS ONE 2011; 6: e21856.
  • 67
    Kitab B, Afifi R, El Feydi AE, et al. Genetic variability of Hepatitis B virus in Morocco. Hong Kong: Institut Pasteur International Network Annual Scientific Meeting, 2010;. (Abstract).
  • 68
    Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet 2011; 378: 7385.
  • 69
    Jenhani F, Ayed K, Gorgi Y, et al. Delta infection in chronic HBs Ag carriers in Tunisia: high prevalence in chronic asymptomatic HBs Ag carriers and in HBs Ag positive cirrhosis. Ann Trop Med Parasitol 1990; 84: 34953.
  • 70
    Belabbes EH. The hepatitis delta virus in Algiers (Algeria). Prog Clin Biol Res 1987; 234: 4434.
  • 71
    Djebbi A, Rebai WK, Bahri O, et al. Serological markers, viral RNA and genotype of hepatitis delta virus in HBs antigen positive Tunisian patients (French). Pathol Biol (Paris) 2009; 57: 51823.
  • 72
    Tedaldi E, Peters L, Neuhaus J, et al. Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study. Clin Infect Dis 2008; 47: 146875.
  • 73
    Ribes J, Cleries R, Rubio A, et al. Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up. Int J Cancer 2006; 119: 68794.
  • 74
    Hooshyar D, Napravnik S, Miller WC, Eron JJ. Effect of hepatitis C coinfection on discontinuation and modification of initial HAART in primary HIV care. AIDS 2006; 20: 57583.
  • 75
    Alter H. Viral hepatitis. Hepatology 2006; 43: S2304.
  • 76
    Berkane S. French Luncheon comment prendre en charge les patients atteints d'hépatite C avec les médicaments disponibles en Algérie. 3rd Paris Hepatitis Conference, Paris, 2009, (Abstract).
  • 77
    El Annnaz H, Arrouchi H, Haoudi F, et al. Les Co-infections VIH-VHC et VIH-VHB à l'HMIMV de Rabat. Troisièmes journées de la Société Marocaine d'Immunologie, 2011 (Abstract).
  • 78
    Maaref F, Kilani B, Ammari L, et al. Prevalence of hepatitis G, B and C virus infections among positive HIV population in a Tunisian Hospital, La Rabta, Tunis (French). Pathol Biol (Paris) 2011; 59: 2136.
  • 79
    Kamal SM, Mahmoud S, Hafez T, EL-Fouly R. Viral hepatitis A to E in South Mediterranean Countries. Medit J Hemat Infect Dis 2010; 2: e2010001.
  • 80
    Kutrani H, El-Gatit A, Shekhteryea A, et al. DemoFigureic factors influencing hepatitis B and C infection in Benghazi. Libyan Arab Jamahiriya. East Mediterr Health J 2007; 13: 8597.
  • 81
    Cacoub P, Ohayon V, Sekkat S, et al. Epidemiologic and virologic study of hepatitis C virus infections in Morocco (French). Gastroenterol Clin Biol 2000; 24: 16973.
  • 82
    Ben Halima S, Bahri O, Maamouri N, et al. Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa. Virol J 2010; 7: 229.
  • 83
    IARC Monographs. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs. Lyon: IARC Press, 1987; 142.
  • 84
    Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74108.
  • 85
    Lu SN, Su WW, Yang SS, et al. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer 2006; 119: 194652.
  • 86
    Ayoola EA, Gadour MO. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection. J Gastroenterol Hepatol 2004; 19: 6659.
  • 87
    Yaghi C, Sharara AI, Rassam P, et al. Hepatocellular carcinoma in Lebanon: etiology and prognostic factors associated with short-term survival. World J Gastroenterol 2006; 12: 357580.